Funds

3

Vintages

2016 to 2024

Reported GAV

$186Mgross asset value on Form ADV; never dry powder

Funds with fundraising evidence

0derived

Investments

52

Portfolio companies

52

Investments, 12m

51

Partner-attributed

1

People

30

Investment professionals

18derived

Co-investors

0derived

LP relationships

0

Stated sectors

aias stated by the firm

Stated geography

uk

Latest Form D

Nov 14, 2025

Latest ADV filing

Mar 26, 2026

Website

missionbiocapital.com

• Occurred

  Mar 29, 2023
  Person left

  Michael Douglas Taylor (Member Of Bioinnovation Capital I, Gp Llc) no longer on Schedule A of Mission Biocapital

  Form ADVobserved 6 days ago
• Occurred

  May 18, 2022
  Person left

  Douglas Kingsley Crawford (Managing Member Mission Biocapital V Gp Llc) no longer on Schedule A of Mission Biocapital

  Form ADVobserved 6 days ago
• Occurred

  May 18, 2022
  Person left

  Peter Parker (Managing Member Of Mission Biocapital V, Gp Llc) no longer on Schedule A of Mission Biocapital

  Form ADVobserved 6 days ago
• Occurred

  Apr 1, 2022
  Person joined

  Loretta Mcclary joined Schedule A of Mission Biocapital as Chief Financial Officer, Bioinnovation Management Llc

  Form ADVobserved 6 days ago
• Occurred

  Apr 1, 2022
  Person joined

  Douglas Kingsley Crawford joined Schedule A of Mission Biocapital as Member, Class A Member Of Bioinnovation Capital I Gp Llc

  Form ADVobserved 6 days ago
• Occurred

  Jul 21, 2021
  Person left

  Anthony S Walsh (Member Of Bioinnovation Capital I, Gp Llc) no longer on Schedule A of Mission Biocapital

  Form ADVobserved 6 days ago
• Occurred

  Mar 29, 2021
  Person left

  Robert Glenn Blazej (Member Of Mission Biocapital V Gp Llc) no longer on Schedule A of Mission Biocapital

  Form ADVobserved 6 days ago
• Occurred

  Apr 1, 2020
  Person joined

  Robert Glenn Blazej joined Schedule A of Mission Biocapital as Member Of Mission Biocapital V Gp Llc

  Form ADVobserved 6 days ago
• Occurred

  Apr 1, 2020
  Person joined

  Peter Parker joined Schedule A of Mission Biocapital as Managing Member Of Mission Biocapital V, Gp Llc

  Form ADVobserved 6 days ago
• Occurred

  Jan 1, 2020
  Person joined

  Michael Douglas Taylor joined Schedule A of Mission Biocapital as Member Of Bioinnovation Capital I, Gp Llc

  Form ADVobserved 6 days ago
• Occurred

  Dec 1, 2019
  Person joined

  Steven Webb Tregay joined Schedule A of Bioinnovation Capital as Member Of Bioinnovation Capital I, Gp

  Form ADVobserved 6 days ago
• Occurred

  Jun 1, 2019
  Person joined

  Anthony S Walsh joined Schedule A of Bioinnovation Capital as Member Of Bioinnovation Capital I, Gp

  Form ADVobserved 6 days ago
• Occurred

  Feb 1, 2017
  Person joined

  Christopher Taylor Carlin joined Schedule A of Mission Biocapital as Chief Compliance Officer Of Bioinnovation Management Llc

  Form ADVobserved 6 days ago
• Occurred

  Apr 21, 2016
  Adviser's first ADV filing

  Bioinnovation Management LLC first filed Form ADV (ERA, venture capital fund adviser exemption)

  Form ADVobserved 6 days ago

Also named here, with no published line of their own (reach them through the firm): Sarika Temme-Bapat (Managing General Partner), Zach Collins (Managing General Partner), Douglas Crawford (Director of Operations, Bay Area), Linda Eng (General Partner), Johannes Fruehauf (Class A Member Of Bioinnovation Capital I, Gp Llc), Jennifer Griffin (Vice President of Finance), Samar Jahan (General Partner), Ulrik B. Nielsen (Accounting and Operations Associate), Nana Kusi Minkah (Chief Financial Officer), Loretta Mcclary (Managing General Partner), Peter Parker (Principal), Chaya Patel (Investment Associate).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:c7fe00df-51f5-4a53-a5ba-d8657a8b03d4

First observed

Sep 12, 2026

Last observed

Sep 17, 2026 2 days ago

Source families

Federal regulator filings, Firm and issuer disclosures

3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.